Skip to main content

Karim De Jong

CFO

Fagron

Equibles does not estimate personal net worth.

About Karim De Jong

Karim De Jong is recorded as CFO at Fagron. Karim De Jong has spoken on 2 earnings calls across 1 company, most recently for Fagron on October 8, 2026. Fagron is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.

Karim De Jong on recent calls

“So the whole growth comes from the 503A facility in Tampa, the new one, and that's mainly driven by strong health and wellness driver, longevity, and of course the telehealth platforms, which in the U.S., as you have asked many times during the calls, it's huge the health platforms yeah maybe to comment on the…”
CFO, Fagron Nine Months 2026 Trading Update ·
“And let me walk you through the first half of the 2026 financial result and provide more color for the full year 2026. In H1 2026, revenues increased by 16% on a reported basis to $552.5 million, driven by acquisitions and organic growth in the regions.”
CFO, Fagron H1 2026 Results Call ·

Affiliation history

  • Fagron

    CFO

    Transcript header (unverified)

    Current

Company network

Fagron

Current role

Drug Manufacturers - Specialty & Generic · Healthcare

CFO

2 appearances Latest appearance 2026-10-08

Recent activity

  • Earnings call

    Fagron Nine Months 2026 Trading Update

    Fagron

  • Earnings call

    Fagron H1 2026 Results Call

    Fagron